TrueNTH solutions: an integrated multi-component intervention to improve the lives of men with prostate cancer in Australia

Not Applicable

Completed

• Conditions: Cancer - Prostate; Public Health - Health service research; Prostate cancer

• Registration Number: ACTRN12617000174381
• Lead Sponsor: Professor Patsy Yates

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-02-02
• Study Completion: 2019-09-30
• Last Update Posted: 29 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 201

Inclusion Criteria

Men will be eligible for the study if they have been diagnosed with prostate cancer and are receiving services from any of the participating sites. His partner/carer must be aged 18+ years; competent to give informed consent; and able to complete questionnaires.

Exclusion Criteria

Men will be excluded from the study if they are:
* too unwell (as determined by treating clinician); and/or
* have difficulties in adequately understanding written or verbal information in English; and/or
* have physical, psychological or cognitive difficulties that would prevent them from participating in the study or completing self-reported outcome measures.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prostate health symptoms as assessed using The Expanded Prostate Cancer Index short form (EPIC-26)[At baseline, and at up to 3 time points during the intervention and 12 months after intervention commencement];Patient psychological distress as assessed using Distress Thermometer and the General Health Questionnaire (GHQ-12)[At baseline, and at up to 3 time points during the intervention and 12 months after intervention commencement];Patient experiences of care as assessed using the Picker Patient Experience Questionnaire (PPE-15) and the National Cancer Control Indicators-Patient Experience Indicator (NCCI-PEx 1-8).[At baseline, and at up to 3 time points during the intervention and 12 months after intervention commencement]